Novacyt announces the completion of the acquisition, by its UK subsidiary, of the entire share capital of Yourgene Health, an international molecular diagnostics group, following approval of a plan of arrangement by the relevant court.

Yourgene develops, manufactures and markets mainly simple and accurate molecular diagnostic and screening solutions for reproductive health and precision medicine, enabling the implementation of genomic medicine.

Its portfolio of in vitro diagnostic products includes, for example, non-invasive prenatal diagnostics for the detection of trisomy and other genetic disorders, as well as screening tests for cystic fibrosis.

Copyright (c) 2023 CercleFinance.com. All rights reserved.